Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Structum 500 mg vs placebo in hip osteoarthritis
2005-000508-15Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2005
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hip osteoarthritis comparing Structum 500 mg capsule twice daily with Placebo (2 arms). Primary endpoint: Pain during walking at 24 weeks. Started Aug 2005; status: completed.
02
Drugs
chondroitin sulfate
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2005-000508-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000508-15.